Class information for:
Level 2: CARDIOPULMONARY BYPASS//APROTININ//PERFUSION-UK

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2030 4913 29.7 73%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
48 92304 HAEMOPHILIA//HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS

Classes in level below (level 1)


ID, lev. below Publications Label for level below
2662 2107 CARDIOPULMONARY BYPASS//PERFUSION-UK//MODIFIED ULTRAFILTRATION
6694 1380 APROTININ//TRANEXAMIC ACID//EPSILON AMINOCAPROIC ACID
18765 471 HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME
19912 420 PROTAMINE//PROTAMINE TOXICITY//PROTAMINE IMMOBILIZATION
21594 355 COLLOIDAL TITRATION//FLOW THROUGH ION SENSOR//POLYION SENSITIVE ELECTRODE
27855 180 BLOOD GAS CONTROL//CARDIOPULMONARY BYPASS MODEL//PERFUSION EDUCATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARDIOPULMONARY BYPASS Author keyword 183 20% 16% 809
2 APROTININ Author keyword 161 45% 6% 271
3 PERFUSION-UK Journal 102 27% 7% 330
4 HEPARIN COATING Author keyword 35 57% 1% 42
5 MODIFIED ULTRAFILTRATION Author keyword 35 86% 0% 18
6 PROTAMINE Author keyword 29 22% 2% 117
7 TRANEXAMIC ACID Author keyword 28 21% 2% 115
8 EXTRACORPOREAL CIRCULATION Author keyword 27 18% 3% 136
9 HEPARIN COATED CIRCUITS Author keyword 15 82% 0% 9
10 ACTIVATED CLOTTING TIME Author keyword 15 38% 1% 31

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CARDIOPULMONARY BYPASS 183 20% 16% 809 Search CARDIOPULMONARY+BYPASS Search CARDIOPULMONARY+BYPASS
2 APROTININ 161 45% 6% 271 Search APROTININ Search APROTININ
3 HEPARIN COATING 35 57% 1% 42 Search HEPARIN+COATING Search HEPARIN+COATING
4 MODIFIED ULTRAFILTRATION 35 86% 0% 18 Search MODIFIED+ULTRAFILTRATION Search MODIFIED+ULTRAFILTRATION
5 PROTAMINE 29 22% 2% 117 Search PROTAMINE Search PROTAMINE
6 TRANEXAMIC ACID 28 21% 2% 115 Search TRANEXAMIC+ACID Search TRANEXAMIC+ACID
7 EXTRACORPOREAL CIRCULATION 27 18% 3% 136 Search EXTRACORPOREAL+CIRCULATION Search EXTRACORPOREAL+CIRCULATION
8 HEPARIN COATED CIRCUITS 15 82% 0% 9 Search HEPARIN+COATED+CIRCUITS Search HEPARIN+COATED+CIRCUITS
9 ACTIVATED CLOTTING TIME 15 38% 1% 31 Search ACTIVATED+CLOTTING+TIME Search ACTIVATED+CLOTTING+TIME
10 MINIMAL EXTRACORPOREAL CIRCULATION 15 71% 0% 12 Search MINIMAL+EXTRACORPOREAL+CIRCULATION Search MINIMAL+EXTRACORPOREAL+CIRCULATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 HIGH DOSE APROTININ 254 77% 4% 172
2 CARDIOPULMONARY BYPASS 240 14% 32% 1555
3 APROTININ 121 34% 6% 291
4 EXTRACORPOREAL CIRCULATION 115 35% 6% 272
5 EPSILON AMINOCAPROIC ACID 67 38% 3% 138
6 ACTIVATED CLOTTING TIME 64 46% 2% 103
7 DOSE APROTININ 60 68% 1% 53
8 OPEN HEART SURGERY 59 16% 7% 341
9 BLOOD LOSS 53 14% 7% 344
10 HEPARIN COATED CIRCUITS 46 70% 1% 39

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PERFUSION-UK 102 27% 7% 330

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials 2004 181 16 88%
Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery 2007 136 133 94%
Inflammatory response to cardiopulmonary bypass - Mechanisms involved and possible therapeutic strategies 1997 432 214 59%
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints 1999 277 84 81%
Drug therapy: Prevention and treatment of major blood loss 2007 148 77 47%
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion 2007 86 220 74%
The current place of tranexamic acid in the management of bleeding 2015 2 13 46%
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update 2002 306 122 45%
Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis 2015 1 26 81%
Tranexamic Acid A Review of its Use in the Treatment of Hyperfibrinolysis 2012 43 143 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EXTRACORPOREAL CIRCULAT 9 38% 0.4% 19
2 CARDIOVASC PERFUS 7 29% 0.4% 20
3 OSLO HEART 6 80% 0.1% 4
4 EDMUND COHEN VASC 5 54% 0.1% 7
5 CARDIOVASC E MALAN 4 34% 0.2% 10
6 CARDIOTHORAC ANESTHESIOL CRIT CARE 4 30% 0.2% 10
7 CARDIAC LEIPZIG 3 43% 0.1% 6
8 NORDLAND CENT HOSP 3 45% 0.1% 5
9 IMMUNOL BLOOD BANK 3 50% 0.1% 4
10 PERFUS UNIT 3 50% 0.1% 4

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000020165 MINIMALLY INVASIVE CARDIAC SURGERY//INTERNAL THORACIC ARTERY//HEART SURGERY FORUM
2 0.0000017539 TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION
3 0.0000016557 HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//LEPIRUDIN
4 0.0000016012 WARFARIN//CYP2C9//VKORC1
5 0.0000011192 ACUTE KIDNEY INJURY//NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN//NGAL
6 0.0000009823 LEFT VENTRICULAR ASSIST DEVICE//VENTRICULAR ASSIST DEVICE//ARTIFICIAL ORGANS
7 0.0000009555 CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE
8 0.0000009383 EXTRACORPOREAL MEMBRANE OXYGENATION//ACUTE RESPIRATORY DISTRESS SYNDROME//VENTILATOR INDUCED LUNG INJURY
9 0.0000009274 PULMONARY MICROCIRCULATION//PRESSURE FLOW PLOTS//CHRONIC INSTRUMENTATION
10 0.0000007434 ELAFIN//SLPI//SECRETORY LEUKOCYTE PROTEASE INHIBITOR